CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Non-Hodgkin's lymphoma (NHL) is a cancer that arises from the transformation of normal B and T lymphocytes (white blood ce...
Phase 1
Huntersville, North Carolina, United States of America and 9 other locations
This is a global Phase 2, open-label, single-arm, multicohort, multicenter study to evaluate efficacy and safety of JCAR017 in adult subjects with r/...
Phase 2
Charlotte, North Carolina, United States and 58 other locations
B-cell Lymphoma is an aggressive and rare cancer of a type of immune cell (a white blood cell responsible for fighting infections). The purp-...
Phase 2
Charlotte, North Carolina, United States and 74 other locations
A Phase 1 Study Evaluating BAFFR-targeting CAR T Cells for Patients with Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma...
Phase 1
Charlotte, North Carolina, United States and 3 other locations
of adult participants with relapsed or refractory (r/r) B-Cell non-Hodgkin lymphoma (B-NHL) or frontline high-risk diffuse...
Phase 1, Phase 2
Charlotte, North Carolina, United States and 29 other locations
pharmacokinetic, pharmacodynamic, and clinical activity of AZD0486, a CD19 x CD3 T-cell engaging bispecific antibody, in subjects with B-cell non...
Phase 1
Charlotte, North Carolina, United States and 28 other locations
This study will evaluate the safety, efficacy, and pharmacokinetics of mosunetuzumab or glofitamab in combination with CELMoDs (CC-220 and/or CC-9928...
Phase 1
Charlotte, North Carolina, United States and 25 other locations
Carcinoma (NPC) and Non-Hodgkin Lymphoma (NHL) in Escalation and diffuse large B-cell lymphoma (DLBCL) in expans...
Phase 1, Phase 2
Charlotte, North Carolina, United States and 17 other locations
with polatuzumab vedotin in participants with diffuse large B-cell lymphoma (DLBCL), follicular lymphoma (FL), and mantle cell lymphoma...
Phase 1, Phase 2
Charlotte, North Carolina, United States and 28 other locations
monotherapy in adult participants with relapsed/refractory B-cell non-Hodgkin lymphoma (NHL) who have received at least tw...
Phase 2
Charlotte, North Carolina, United States and 84 other locations
Clinical trials
Research sites
Resources
Legal